ICSB2012:International Workshop on Cancer Systems Biology

Welcome to ICSB2012!

July 5th and 6th, Jilin University, Changchun, China

The goal of this workshop is to bring together researchers and clinicians with a wide range of expertise but sharing a common interest: gaining improved understanding about cancer, to present their insights about cancer. Specifically we are interested in gaining new and systems-level understanding about cancer formation, progression, and diagnosis through exchange of ideas and experiences by the invited speakers and the attendees of the workshop.

For this workshop, we have invited 21 invited speakers, with 10 from China and 11 from overseas, consisting of cancer biologists, cancer clinicians, cancer omic data analysts and computational modelers. We aim for integration of different perspectives about cancer, which could lead to new ways of thinking about identification of the key drivers of cancer as well as about identification of effective markers for cancer diagnosis. In addition to the 21 invited talks, the workshop welcomes posters from the workshop attendees to share their insights and experiences about cancer research.

We have successfully held the ICSB2011. We look forward to an exciting meeting in Changchun in July 2012.

Alphabetical Order by Last Names

Dr. Juan Cui
University of Georgia, USA

Talk : Whole-genome sequence analysis reveals new insights about gastric cancer
Dr. Luonan Chen
Shanghai Institutes for Biological Sciences, CAS, China

Talk : Network rewiring changes the roles of p53 from suppressing to promoting tumorigenesis
Dr. Shujun Cheng
Chinese Academy of Medical Sciences, China

Talk : Cancer: molecular network disease
Dr. Jingtang Dong
Emory University, USA

Talk : Genetic alterations in prostate cancer
Dr. Yajun Guo
Cancer Center, Hospital 301, China

Talk : Nanoimmunotherapy: A new way for treatment of cancer
Dr. Zheng Guo
Harbin Medical University, China

Talk : Multi-level reproducibility of diagnostic biomarkers for cancer
Dr. Shulin Li
MD Anderson, USA

Talk : Electroporation immune therapy for malignancy
Dr. Xiaole Liu
Harvard University/Dana-Farber, USA

Talk : lncRNA regulation in cancer
Dr. ZhiRen Liu
Georgia State University, USA

Talk : PKM2, a key system biology junction point, for coordinating Metabolism Adjustments, Gene Expression, and Angiogenesis during tumor progression
Dr. Chaonan(Miles) Qian
SunYat Sen University , China

Talk : Exploration of molecular mechanisms promoting metastasis of nasopharyngeal carcinoma
Dr. Shiyong Sun
Emory University, USA

Talk : Oncogene-induced death receptor 5 expression in cancer
Dr. Yu Shyr
Vanderbilt University, USA

Talk : Statistical Bioinformatics Approaches to Designing and Analyzing Sequencing Data
Dr. Yaping Tian
Department of Biochemistry, Hospital 301, China

Talk : HBV infection initiated liver injury and serum peptidomics changes
Dr. Edwin Wang
Canadian Research Council, Canada

Talk : Personalized cancer healthcare: A systems biology approach
Dr. Wenyi Wang
MD Anderson, USA

Talk : Determining probability of rare variants in sequencing studies for familial cancer syndromes
Dr. Dong Xu
University of Missouri, USA

Talk : Computational analyses of DNA methylation features in cancer
Dr. Ying Xu
University of Georgia, USA

Talk : Are driver mutations really drivers of cancer formation or progression?
Dr. Weiping Zou
University of Michigan, USA

Talk : Immune and biological networks in the cancer microenvironment
Dr. Wei Zhang
MD Anderson, USA

Talk : Integrated genomics: impact on personalized cancer medicine
Dr. Bing Zhang
Vanderbilt, USA

Talk : Deciphering genomic alterations in colorectal cancer through subtype-specific driver networks
Dr. Juan Cui
University of Georgia, USA

Talk : Whole-genome sequence analysis reveals new insights about gastric cancer
Dr. Luonan Chen
Shanghai Institutes for Biological Sciences, CAS, China

Talk : Network analysis in chronic hepatitis B and C hepatic lesion reveals ...
Dr. Shujun Cheng
Chinese Academy of Medical Sciences, China

Talk : Cancer: molecular network disease
Dr. Jingtang Dong
Emory University, USA

Talk : Genetic alterations in prostate cancer
Dr. Yajun Guo
Cancer Center, Hospital 301, China

Talk : Nanoimmunotherapy: A new way for treatment of cancer
Dr. Zheng Guo
Harbin Medical University, China

Talk : Multi-level reproducibility of diagnostic biomarkers for cancer
Dr. Shulin Li
MD Anderson, USA

Talk : Electroporation immune therapy for malignancy
Dr. Xiaole Liu
Harvard University/Dana-Farber, USA

Talk : lncRNA regulation in cancer
Dr. Yixue Li
Shanghai Institutes for Biological Sciences, CAS, China

Talk : Evolution and function of protein phosphorylation
Dr. ZhiRen Liu
Georgia State University, USA

Talk : PKM2, a key system biology junction point, for coordinating Metabolism Adjustments, Gene Expression, and Angiogenesis during tumor progression
Dr. Chaonan Qian
SunYat Sen University , China

Talk : Exploration of molecular mechanisms promoting metastasis of nasopharyngeal carcinoma
Dr. Shiyong Sun
Emory University, USA

Talk : Oncogene-induced death receptor 5 expression in cancer
Dr. Yu Shyr
Vanderbilt University, USA

Talk : Statistical Bioinformatics Approaches to Designing and Analyzing Sequencing Data
Dr. Yaping Tian
Department of Biochemistry, Hospital 301, China

Talk : HBV infection initiated liver injury and serum peptidomics changes
Dr. Edwin Wang
Canadian Research Council, Canada

Talk : Personalized cancer healthcare: A systems biology approach
Dr. Wenyi Wang
MD Anderson, USA

Talk : Risk assessment for familial cancer syndromes
Dr. Dong Xu
University of Missouri, USA

Talk : Computational analyses of DNA methylation features in cancer
Dr. Ying Xu
University of Georgia, USA

Talk : Are driver mutations really drivers of cancer formation or progression?
Dr. Weiping Zou
University of Michigan, USA

Talk : Immune and biological networks in the cancer microenvironment
Dr. Wei Zhang
MD Anderson, USA

Talk : Integrated genomics: impact on personalized cancer medicine
Dr. Bing Zhang
Vanderbilt, USA

Talk : Deciphering genomic alterations in colorectal cancer through subtype-specific driver networks